FDG-PET/CT in managing infection in patients with hematological malignancy: clinician knowledge and experience in Australia-Reference-Cited by-同舟云学术

FDG-PET/CT in managing infection in patients with hematological malignancy: clinician knowledge and experience in Australia

Published:2019-04-05 Issue:10 Volume:60 Page:2471-2476
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Douglas Abby P.¹²³^ORCID,Thursky Karin A.¹²³⁴⁵^ORCID,Worth Leon J.¹²³⁵^ORCID,Harrison Simon James²³⁶⁷^ORCID,Hicks Rod John²⁸^ORCID,Slavin Monica A.¹²³⁴^ORCID

Affiliation:

1. Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Australia;

2. Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia;

3. National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Australia;

4. Victorian Infectious Diseases Service, The Peter Doherty Institute for Immunity and Infection, Royal Melbourne Hospital, Melbourne, Australia;

5. National Centre for Antimicrobial Stewardship, Melbourne, Australia;

6. Department of Haematology, Peter MacCallum Cancer Centre, Melbourne, Australia;

7. Department of Haematology, Royal Melbourne Hospital, Melbourne, Australia;

8. Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2019.1590571

Reference20 articles.

1. European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia

2. Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients (allogeneic SCT excluded): updated guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)

3. The role of 18F-FDG PET/CT for the diagnosis of infections in patients with hematological malignancies and persistent febrile neutropenia

4. Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Usefulness of 18F-FDG PET-CT in the Management of Febrile Neutropenia: A Retrospective Cohort from a Tertiary University Hospital and a Systematic Review;Microorganisms;2024-01-31

2. Evaluating the cost-effectiveness of [18F]FDG-PET/CT for investigation of persistent or recurrent neutropenic fever in high-risk haematology patients;Cancer Imaging;2023-12-15

3. Adoption value of support vector machine algorithm-based computed tomography imaging in the diagnosis of secondary pulmonary fungal infections in patients with malignant hematological disorders;Open Life Sciences;2023-01-01

4. [18F]FDG-PET-CT in neutropenic fever: a picture searching for a frame(work);The Lancet Haematology;2022-08

5. Optimising Antimicrobial Selection and Duration in the Treatment of Febrile Neutropenia in Children;Infection and Drug Resistance;2021-03